NJ High Court OKs Roche's Bids To Review Accutane Rulings
By Bill Wichert (December 8, 2017, 8:22 PM EST) -- Hoffmann-La Roche Ltd. has convinced the New Jersey Supreme Court to review two state appellate decisions related to the company's acne medication Accutane, with the justices agreeing to consider rulings over the adequacy of the drug's label and the admissibility of expert testimony.
In orders made available Friday, the state's highest court granted separate petitions for certification filed by the pharmaceutical giant in challenging appellate opinions, issued three days apart in July, that upended trial court victories for the company in multicounty litigation over Accutane.
The Supreme Court also granted a cross-petition for certification filed by plaintiffs over how the first...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!